Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.

[1]  Mathias W. Hofmann,et al.  An automated application for deconvolution of circular dichroism spectra of small peptides. , 2007, Analytical biochemistry.

[2]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[3]  L. Estrada,et al.  Inhibition of protein misfolding and aggregation by small rationally-designed peptides. , 2006, Current pharmaceutical design.

[4]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[5]  Mohammed Abid,et al.  Organofluorine inhibitors of amyloid fibrillogenesis. , 2006, Biochemistry.

[6]  H. Möhwald,et al.  Adsorption of amyloid beta-peptide at polymer surfaces: a neutron reflectivity study. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.

[7]  W. Norde,et al.  Conformational changes of the amyloid beta-peptide (1-40) adsorbed on solid surfaces. , 2005, Macromolecular bioscience.

[8]  M. Coelho,et al.  The Conformation of B18 Peptide in the Presence of Fluorinated and Alkylated Nanoparticles , 2005, Chembiochem : a European journal of chemical biology.

[9]  Pawel Sikorski,et al.  Molecular basis for amyloid fibril formation and stability. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. M. González-García,et al.  Arrangement of SDS adsorbed layer on carbonaceous particles by zeta potential determinations , 2004 .

[11]  E. Vieira,et al.  Change and stabilization of the amyloid-beta(1-40) secondary structure by fluorocompounds. , 2003, Biochimica et biophysica acta.

[12]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Good,et al.  Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity. , 2002, Biotechnology and bioengineering.

[14]  R. Dimova,et al.  Polyampholyte-Dressed Micelles of Fluorinated and Hydrogenated Dodecanoic Acid , 2002 .

[15]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[16]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[17]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[18]  S. Lin,et al.  Temperature-induced conformational changes in amyloid beta(1-40) peptide investigated by simultaneous FT-IR microspectroscopy with thermal system. , 2001, Biophysical chemistry.

[19]  N. Sreerama,et al.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. , 2000, Analytical biochemistry.

[20]  D. Selkoe,et al.  Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.

[21]  C. Geourjon,et al.  Involvement of electrostatic interactions in the mechanism of peptide folding induced by sodium dodecyl sulfate binding. , 2000, Biochemistry.

[22]  P. Fraser,et al.  Structural studies of soluble oligomers of the alzheimer β-amyloid peptide , 2000 .

[23]  E. Vieira,et al.  Amyloid–β-Sheet Formation at the Air-Water Interface , 1999 .

[24]  D. Holtzman,et al.  In situ atomic force microscopy study of Alzheimer’s β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation , 1999 .

[25]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[26]  George B. Benedek,et al.  Temperature dependence of amyloid β-protein fibrillization , 1998 .

[27]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[28]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Reed,et al.  A set of constructed type spectra for the practical estimation of peptide secondary structure from circular dichroism. , 1997, Analytical biochemistry.

[30]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[31]  H. Vinters,et al.  Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .

[32]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[33]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[34]  C. Barrow,et al.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.

[35]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[36]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[37]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Kirkitadze,et al.  Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Fraser,et al.  Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. , 2000, Journal of molecular biology.

[40]  E. Vieira,et al.  Amyloid-beta-sheet formation at the air-water interface. , 1999, Biophysical journal.

[41]  D. Holtzman,et al.  In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Vinters,et al.  Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. , 1996, Biochemistry.

[43]  N. Sreerama,et al.  Estimation of protein secondary structure from circular dichroism spectra: inclusion of denatured proteins with native proteins in the analysis. , 2000, Analytical biochemistry.

[44]  D. Teplow,et al.  Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.

[45]  P E Wright,et al.  Defining solution conformations of small linear peptides. , 1991, Annual review of biophysics and biophysical chemistry.

[46]  C. Cotman,et al.  In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. , 1991, Brain research.

[47]  K. Dill,et al.  Denatured states of proteins. , 1991, Annual review of biochemistry.

[48]  D. Selkoe,et al.  X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Stöber,et al.  Controlled growth of monodisperse silica spheres in the micron size range , 1968 .

[50]  L. Duysens,et al.  The flattening of the absorption spectrum of suspensions, as compared to that of solutions. , 1956, Biochimica et biophysica acta.